Search Results - "Tobert, Kathryn E"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2

    Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death by Tobert, Kathryn E., Bos, J. Martijn, Garmany, Ramin, Ackerman, Michael J.

    “…Within the last 5 years, cardiac society guidelines have begun to acknowledge shared decision making (SDM) for the athlete with sudden cardiac…”
    Get full text
    Journal Article
  3. 3

    Outcomes of Athletes With Genetic Heart Diseases and Implantable Cardioverter-Defibrillators Who Chose to Return to Play by Tobert, Kathryn E., Bos, J. Martijn, Cannon, Bryan C., Ackerman, Michael J.

    Published in Mayo Clinic proceedings (01-11-2022)
    “…To evaluate outcomes for athletes with a genetic heart disease (GHD) and an implantable cardioverter-defibrillator (ICD) after return-to-play (RTP) approval…”
    Get full text
    Journal Article
  4. 4

    Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death by Martinez, Katherine A., Bos, J. Martijn, Baggish, Aaron L., Phelan, Dermot M., Tobert, Kathryn E., Newman, Darrel B., Scherer, Erica, Petek, Bradley J., Ackerman, Michael J., Martinez, Matthew W.

    “…People diagnosed with genetic heart diseases (GHDs) associated with sudden cardiac death (SCD) have historically been restricted from competitive sports…”
    Get full text
    Journal Article
  5. 5

    Bilateral cardiac sympathetic denervation in patients with congenital long QT syndrome by Tobert, Kathryn E., Bos, J. Martijn, Moir, Christopher, Polites, Stephanie F., Ackerman, Michael J.

    Published in Heart rhythm (01-07-2023)
    “…Long QT syndrome (LQTS) is a potentially lethal yet treatable genetic heart disease for which left cardiac sympathetic denervation (LCSD) is a class I…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Single Construct Suppression and Replacement Gene Therapy for the Treatment of All CALM1 -, CALM2 -, and CALM3 -Mediated Arrhythmia Disorders by Hamrick, Samantha K, Kim, C S John, Tester, David J, Gencarelli, Manuela, Tobert, Kathryn E, Gluscevic, Martina, Ackerman, Michael J

    “…CaM (calmodulin)-mediated long-QT syndrome is a genetic arrhythmia disorder (calmodulinopathies) characterized by a high prevalence of life-threatening…”
    Get full text
    Journal Article
  8. 8

    Genome sequencing in a genetically elusive multigenerational long QT syndrome pedigree identifies a novel LQT2-causative deeply intronic KCNH2 variant by Tobert, Kathryn E., Tester, David J., Zhou, Wei, Haglund-Turnquist, Carla M., Giudicessi, John R., Ackerman, Michael J.

    Published in Heart rhythm (01-06-2022)
    “…Most of the long QT syndrome (LQTS) stems from pathogenic variants in KCNQ1, KCNH2, or SCN5A. However, ∼10%–20% of LQTS index cases remain genotype-negative…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Diagnostic accuracy of the 12-lead electrocardiogram in the first 48 hours of life for newborns of a parent with congenital long QT syndrome by Perez, Yalile, Tobert, Kathryn E., Saunders, Michaela J., Sorensen, Katrina B., Bos, J. Martijn, Ackerman, Michael J.

    Published in Heart rhythm (01-06-2022)
    “…Long QT syndrome (LQTS) is an autosomal dominant disorder characterized by a prolonged QT interval. Electrocardiographic (ECG) screening in the first 48 hours…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Abstract 14277: Diagnostic Accuracy of the 12-lead Electrocardiogram in the First 48 Hours of Life in Neonates From a Parent With Genotype Positive Long QT Syndrome by Tobert, Kathryn E, Perez, Yalile, Bos, Martijn, Ackerman, Michael J

    Published in Circulation (New York, N.Y.) (16-11-2021)
    “…IntroductionLong QT syndrome (LQTS) is an autosomal dominant disorder characterized by a prolonged QT interval on a 12-lead electrocardiogram (ECG). Cascade…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Abstract 14385: Genome Sequencing and Re-Engineered Heart Cell-Disease Modeling Identifies a Novel Deep Intronic Variant in a Multi-Generational Long QT Syndrome Pedigree by Tobert, Kathryn E, Tester, David J, Zhou, Wei, Haglund-Turnquist, Carla, Giudicessi, John, Ackerman, Michael J

    Published in Circulation (New York, N.Y.) (16-11-2021)
    “…IntroductionMost of long QT syndrome (LQTS) is explained by pathogenic variants in KCNQ1, KCNH2, or SCN5A. However, ~10-20% of LQTS index cases remain…”
    Get full text
    Journal Article
  16. 16

    Abstract 15036: Suppression-Replacement Gene Therapy for CALM1-Mediated Long QT Syndrome by Tobert, Kathryn E, Hamrick, Samantha K, Gluscevic, Martina, Tester, David J, Kim, CS John, Ackerman, Michael J

    Published in Circulation (New York, N.Y.) (08-11-2022)
    “…IntroductionCalmodulin (CaM)-mediated long QT syndrome (CaM-LQTS) is a genetic arrhythmia disorder characterized by a high prevalence of life-threatening…”
    Get full text
    Journal Article
  17. 17

    Abstract 15101: Return-to-Work for Patients in High-Risk Professions Diagnosed With a Sudden Death-Predisposing Genetic Heart Disease by Kulkarni, Veda K, Tobert, Kathryn E, Bos, Johan M, Cowl, Clayton T, MacIntyre, Ciorsti, Giudicessi, John R, Ackerman, Michael J

    Published in Circulation (New York, N.Y.) (08-11-2022)
    “…IntroductionSudden cardiac arrest (SCA) and death (SCD) are the most serious sequelae of many genetic heart diseases (GHDs). Increased awareness of this has…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20